Form 8-K - Current report:
SEC Accession No. 0001437749-25-001556
Filing Date
2025-01-22
Accepted
2025-01-22 16:01:47
Documents
14
Period of Report
2025-01-22
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K govx20250122_8k.htm   iXBRL 8-K 27843
  Complete submission text file 0001437749-25-001556.txt   174941

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA govx-20250122.xsd EX-101.SCH 3852
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20250122_def.xml EX-101.DEF 13384
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20250122_lab.xml EX-101.LAB 17551
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20250122_pre.xml EX-101.PRE 13361
16 EXTRACTED XBRL INSTANCE DOCUMENT govx20250122_8k_htm.xml XML 4654
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

EIN.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39563 | Film No.: 25545899
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)